Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment (2019) Schubert J, Braemer D, Huttner H, Gerner S, Fuhrer H, Melzer N, Dik A, et al. Journal article Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) Von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, et al. Journal article Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions (2018) Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, et al. Journal article Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS (2018) Sauer EM, Schliep S, Manger B, Lee DH, Linker R Journal article Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS (2017) Rothhammer V, Borucki DM, Sanchez MIG, Mazzola MA, Hemond CC, Regev K, Paul A, et al. Journal article Deregulated Fcγ receptor expression in patients with CIDP. (2015) Quast I, Cueni F, Nimmerjahn F, Tackenberg B, Luenemann JD Journal article